SCHEMBL7420912

SCHEMBL7420912

NC(Cc1ccc2oc(-c3c(Cl)cccc3Cl)nc2c1)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 3/20 0.68
ITGA4 P13612 3/20 0.68
ITGB7 P26010 3/20 0.68
PTPRA P18433 1/20 0.54
PTPRB P23467 1/20 0.54
HIF1A Q16665 2/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
BRCA1 P38398 1/20 0.49
PKM P14618 1/20 0.48
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SLC7A5 Q01650 2/20 0.43
KDM4E B2RXH2 2/20 0.42
USP2 O75604 1/20 0.42
EGFR P00533 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420913 1.00 ITGB1 (0.68) ITGB1ITGA4ITGB7PTPRAPTPRB
SCHEMBL7413757 0.91 ITGB1 (0.57) ITGB1ITGA4ITGB7PTPRAPTPRB
SCHEMBL7413758 0.91 ITGB1 (0.57) ITGB1ITGA4ITGB7PTPRAPTPRB
SCHEMBL1068034 0.83 PTPRA (0.61) ITGB1ITGA4ITGB7PTPRAPTPRB
SCHEMBL1068031 0.83 PTPRA (0.61) ITGB1ITGA4ITGB7PTPRAPTPRB
SCHEMBL7418848 0.79 ITGB1 (0.57) ITGB1ITGA4ITGB7ALDH1A1TP53
SCHEMBL16971289 0.78 PTPRA (0.55) ITGB1ITGA4ITGB7PTPRAPTPRB
SCHEMBL16971288 0.78 PTPRA (0.55) ITGB1ITGA4ITGB7PTPRAPTPRB
SCHEMBL2307975 0.77 PTPRA (0.58) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL5873451 0.76 ITGB1 (0.55) ITGB1ITGA4ITGB7HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed